[Home] [Databases] [Search] [WorldLII] [Feedback] [Help]

[Advanced Search] [Search Help] [Results Interface Help]
AustLII Databases - Documents found: 13 for (" cth num reg nhbar20105n296o2010635")

AustLII's End of Year Appeal - If you value the service we provide, please support us by making a contribution today.

View Options

  1. NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO5) (SLI NO 296 OF 2010) - SCHEDULE 1 Amendments [100%]
    (From Commonwealth Numbered Regulations; 1 January 2010; 65 KB)   

  2. NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO5) (SLI NO 296 OF 2010) - REG 2 Commencement [83%]
    (From Commonwealth Numbered Regulations; 1 January 2010; 1 KB)   

  3. NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO5) (SLI NO 296 OF 2010) - REG 1 Name of Regulations [79%]
    (From Commonwealth Numbered Regulations; 1 January 2010; 1 KB)   

  4. NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO5) (SLI NO 296 OF 2010) - REG 10 Transitional -- listed brand moving from third transitional disclosure cycle to main disclosure cycle [79%]
    (From Commonwealth Numbered Regulations; 1 January 2010; 4 KB)   

  5. NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO5) (SLI NO 296 OF 2010) - REG 4 Definitions for Part 2 [79%]
    (From Commonwealth Numbered Regulations; 1 January 2010; 3 KB)   

  6. NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO5) (SLI NO 296 OF 2010) - REG 6 Transitional -- listed brand subject to price disclosure and annual reporting period does not end before 1 December 2010 -- data collection period [75%]
    (From Commonwealth Numbered Regulations; 1 January 2010; 7 KB)   

  7. NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO5) (SLI NO 296 OF 2010) - REG 9 Transitional -- listed brand moving from first or second transitional disclosure cycle to main disclosure cycle [75%]
    (From Commonwealth Numbered Regulations; 1 January 2010; 3 KB)   

  8. NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO5) (SLI NO 296 OF 2010) - REG 3 Amendment of National Health (Pharmaceutical Benefits) Regulations 1960 [70%]
    (From Commonwealth Numbered Regulations; 1 January 2010; 1 KB)   

  9. NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO5) (SLI NO 296 OF 2010) - REG 5 Transitional -- listed brand subject to price disclosure and annual reporting period ends before 1 December 2010 [70%]
    (From Commonwealth Numbered Regulations; 1 January 2010; 4 KB)   

  10. NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO5) (SLI NO 296 OF 2010) - REG 7 Transitional -- listed brand subject to price disclosure and annual reporting period does not end before 1 December 2010 -- reporting period and information [62%]
    (From Commonwealth Numbered Regulations; 1 January 2010; 5 KB)   

  11. NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO5) (SLI NO 296 OF 2010) - NOTES [58%]
    (From Commonwealth Numbered Regulations; 1 January 2010; 12 KB)   

  12. NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO5) (SLI NO 296 OF 2010) - REG 8 Transitional -- listed brand having same drug and manner of administration as listed brand already subject to price disclosure requirements -- first reporting period for brand in third transitional cycle [54%]
    (From Commonwealth Numbered Regulations; 1 January 2010; 4 KB)   

  13. NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO5) (SLI NO 296 OF 2010) EXPLANATORY STATEMENT [4%]
    (From Commonwealth Numbered Regulations Explanatory Statements; 87 KB)   

AustLII: Feedback | Privacy Policy | Disclaimers
URL: http://classic.austlii.edu.au/form/search/